Upper Gastrointestinal Bleeding in Patients with Aspirin and Clopidogrel Co-Therapy
Authors:
- Fook-Hong NgFNFook-Hong Ng
- Kwok-Fai LamKLKwok-Fai Lam
- Siu-Yin WongSWSiu-Yin Wong
- Chee-My ChangCCChee-My Chang
- Yuk-Kong LauYLYuk-Kong Lau
- Wai-Cheung YuenWYWai-Cheung Yuen
- Wai-Ming ChuWCWai-Ming Chu
- Benjamin C.Y. WongBWBenjamin C.Y. Wong
- 25 June 2008
- journal article
- Published by S. Karger AG in Digestion
- Vol. 77 (3-4) , 173-177
Abstract
Introduction: The major complication of aspirin and clopidogrel (A+C) co-therapy is upper gastrointestinal bleeding (UGIB). However, data are unavailable for real-life situations. Furthermore, the treatment effect of antisecretory agents is unknown. Aim: This cohort study aimed to determine the occurrence of UGIB. The treatment effect of H2-receptor antagonist (H2RA) and proton pump inhibitor (PPI) was also analyzed. Method: The records of 987 consecutive patients on A+C co-therapy between January 2001 and September 2006 were analyzed. The follow-up ended on the dates of a first occurrence of UGIB, stopping A+C co-therapy, a change in the antisecretory class, death, or March 2007. Results: After a follow-up of 5.8 ± 6.5 months, UGIB occurred in 39 (4.0%) patients. PPI, H2RA and control were prescribed in 213, 287 and 487 patients respectively. After adjustment for age, dose of aspirin, previous UGIB and duration of treatment, the risk was marginally reduced by H2RA (OR = 0.43, 95% CI 0.18–0.91, p = 0.04) and significantly reduced by PPI (OR = 0.04, 95% CI 0.002–0.21, p = 0.002), as compared to control. Conclusion: The occurrence of UGIB associated with A+C co-therapy for a median of 5.8 months was 4.0%. Co-prescription with PPI was associated with a lower risk.Keywords
This publication has 9 references indexed in Scilit:
- Gastrointestinal Bleeding in Patients Receiving a Combination of Aspirin, Clopidogrel, and Enoxaparin in Acute Coronary SyndromeAmerican Journal of Gastroenterology, 2008
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin‐induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re‐bleeding risk — a single‐blind, randomized controlled studyAlimentary Pharmacology & Therapeutics, 2004
- Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary SyndromesCirculation, 2003
- High incidence of clopidogrel‐associated gastrointestinal bleeding in patients with previous peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 2003
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJACC, 2002
- Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin UseNew England Journal of Medicine, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal BleedingNew England Journal of Medicine, 2000